Dr. Hyunseok Kang, MD

Dr. Kang practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Kang's NPI, 1316108509, was assigned on June 19, 2008. Dr. Kang graduated from Yonsei University College of Medicine in 2002. Dr. Kang's California license number on file is C156305.

Dr. Kang's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Kang's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Kang is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Kang to 3 more hospitals and 5 medical groups, each named with a free account. Dr. Kang's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kang practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kang is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kang's licenses on file in 3 states: California, Maryland and Georgia.

Dmand AI lists breast cancer, chronic leukemia, lung cancer and lymphoma among the conditions Dr. Kang treats.

CMS data shows 363 Medicare services from Dr. Kang across 3 procedure codes in 2024, all of them office visits, for 135 Medicare patients. Medicare paid $42,557 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 135 Medicare patients who saw Dr. Kang in 2024. The largest group is 65 to 74, with 66 patients. 62% of them have high blood pressure, and 56% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kang's median patient age at 69, with 40% women.

In 2024, Dr. Kang wrote 209 Medicare Part D claims for 58 patients. 61% of them were for generic drugs. CMS names the drug for 143 of them, across 7 drugs with 11 or more claims each, at $1,034,503 in total drug cost. In 2023, CMS named 176 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kang for performance year 2024, reported as part of a group. Dr. Kang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kang as offering telehealth.

Dmand AI links 72 papers to Dr. Kang, published from 2010 to 2025. 2018 was the busiest year, with 12. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Squamous Cell Carcinoma of Head and Neck. Dr. Kang has published most often in Laryngoscope. Dr. Kang's most frequent co-authors are Harry Quon, MD, Carole Fakhry, MD and Patrick Ha, MD.

Dmand AI links Dr. Kang to 14 clinical trials, 7 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Adenoid Cystic, Squamous Cell Carcinoma of Head and Neck and Adenocarcinoma. Hyunseok Kang, MD sponsors the most, 2.

CMS Open Payments shows 69 general payments to Dr. Kang from 18 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 50% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $22,298.

Dmand AI lists 2 awards for Dr. Kang, most recently CMS Stage 1 EHR in 2015. Dr. Kang serves on Oral Head and Neck Site Committee UCSF Helen Diller Comprehensive Comprehensive Cancer Center, Protocol Review Committee UCSF Helen Diller Family Comprehensive Cancer Center and Membership Committee Society for Immunotherapy of Cancer.

Dr. Kang graduated from Yonsei University College of Medicine in 2002. Dr. Kang is a member of AACR, ACP, AMA, ASCO, ATA and International Thyroid Oncology Group (ITOG).

Dr. Kang is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.